Risk factor scoring for coronary heart disease.
作者信息
Hense Hans-Werner
出版信息
BMJ. 2003 Nov 29;327(7426):1238-9. doi: 10.1136/bmj.327.7426.1238.
Abstract
摘要
相似文献
1
Risk factor scoring for coronary heart disease.冠心病的危险因素评分
BMJ. 2003 Nov 29;327(7426):1238-9. doi: 10.1136/bmj.327.7426.1238.
2
Re: "Effects of past and recent blood pressure and cholesterol level on coronary heart disease and stroke mortality, accounting for measurement error".
Am J Epidemiol. 2008 Feb 15;167(4):502-3; author reply 503-4. doi: 10.1093/aje/kwm387. Epub 2008 Jan 17.
3
4
Social class and nutrition in coronary heart disease.
Prof Nurse. 1999 Aug;14(11):750-3.
5
Coronary heart disease: risk factor management.冠心病：危险因素管理。
Nurs Stand. 2004;19(13):47-54; quiz 55-6. doi: 10.7748/ns2004.12.19.13.47.c3775.
6
Commentary: Alcohol and mortality: diminishing returns for benefits of alcohol.
Int J Epidemiol. 2005 Feb;34(1):205-6. doi: 10.1093/ije/dyi003. Epub 2005 Jan 13.
7
Women's health. Factors linking women and CHD.
Nurs Times. 1995;91(10):29-31.
8
Heart death rates show a nation of inequalities.
Health Serv J. 2008 Jan 17;118(6089):4-5.
9
What is appropriate coronary assessment prior to abdominal aortic surgery?腹主动脉手术前合适的冠状动脉评估是什么？
Eur J Vasc Endovasc Surg. 2003 Jun;25(6):487-92. doi: 10.1053/ejvs.2002.1832.
10
Coronary disease surveillance: a public heath imperative.
Eur Heart J. 2007 Sep;28(17):2051-2. doi: 10.1093/eurheartj/ehm323. Epub 2007 Aug 5.
引用本文的文献
1
Comparative performance of pooled cohort equations and Framingham risk scores in cardiovascular disease risk classification in a slum setting in Nairobi Kenya.肯尼亚内罗毕贫民窟环境中，合并队列方程和弗雷明汉风险评分在心血管疾病风险分类中的比较表现。
Int J Cardiol Heart Vasc. 2020 Apr 28;28:100521. doi: 10.1016/j.ijcha.2020.100521. eCollection 2020 Jun.
2
Pharmacotherapy Evaluation and Utilization in Coronary Artery Bypass Grafting Patients in Kosovo during the Period 2016-2017.2016 - 2017年科索沃冠状动脉搭桥术患者的药物治疗评估与应用
Open Access Maced J Med Sci. 2018 Mar 12;6(3):498-505. doi: 10.3889/oamjms.2018.132. eCollection 2018 Mar 15.
3
Inflammatory therapeutic targets in coronary atherosclerosis-from molecular biology to clinical application.冠状动脉粥样硬化中的炎症治疗靶点：从分子生物学到临床应用。
Front Physiol. 2014 Nov 21;5:455. doi: 10.3389/fphys.2014.00455. eCollection 2014.
4
Role of coronary artery calcium score and coronary CT angiography in the diagnosis and risk stratification of individuals with suspected coronary artery disease.冠状动脉钙化积分和冠状动脉 CT 血管成像在疑似冠心病患者的诊断和危险分层中的作用。
Curr Cardiol Rep. 2011 Aug;13(4):271-9. doi: 10.1007/s11886-011-0191-4.
5
Does consideration of either psychological or material disadvantage improve coronary risk prediction? Prospective observational study of Scottish men.考虑心理或物质方面的不利因素是否能改善冠心病风险预测？对苏格兰男性的前瞻性观察研究。
J Epidemiol Community Health. 2007 Sep;61(9):833-7. doi: 10.1136/jech.2006.055921.
6
Predicting prognosis in stable angina--results from the Euro heart survey of stable angina: prospective observational study.预测稳定型心绞痛的预后——欧洲稳定型心绞痛心脏调查结果：前瞻性观察研究
BMJ. 2006 Feb 4;332(7536):262-7. doi: 10.1136/bmj.38695.605440.AE. Epub 2006 Jan 13.
本文引用的文献
1
Predictive accuracy of the Framingham coronary risk score in British men: prospective cohort study.弗雷明汉姆冠心病风险评分对英国男性的预测准确性：前瞻性队列研究。
BMJ. 2003 Nov 29;327(7426):1267. doi: 10.1136/bmj.327.7426.1267.
2
Are the Framingham and PROCAM coronary heart disease risk functions applicable to different European populations? The PRIME Study.弗雷明汉和PROCAM冠心病风险函数是否适用于不同的欧洲人群？PRIME研究。
Eur Heart J. 2003 Nov;24(21):1903-11. doi: 10.1016/j.ehj.2003.09.002.
3
An adaptation of the Framingham coronary heart disease risk function to European Mediterranean areas.弗明汉姆冠心病风险函数在欧洲地中海地区的适应性调整。
J Epidemiol Community Health. 2003 Aug;57(8):634-8. doi: 10.1136/jech.57.8.634.
4
Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project.欧洲致命性心血管疾病十年风险评估：SCORE项目
Eur Heart J. 2003 Jun;24(11):987-1003. doi: 10.1016/s0195-668x(03)00114-3.
5
Framingham risk function overestimates risk of coronary heart disease in men and women from Germany--results from the MONICA Augsburg and the PROCAM cohorts.弗雷明汉风险函数高估了来自德国的男性和女性患冠心病的风险——莫妮卡奥格斯堡研究和普罗卡姆队列研究的结果
Eur Heart J. 2003 May;24(10):937-45. doi: 10.1016/s0195-668x(03)00081-2.
6
A cross-validation of risk-scores for coronary heart disease mortality based on data from the Glostrup Population Studies and Framingham Heart Study.基于格罗斯楚普人群研究和弗雷明汉心脏研究数据的冠心病死亡率风险评分交叉验证。
Int J Epidemiol. 2002 Aug;31(4):817-22. doi: 10.1093/ije/31.4.817.
7
Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation.弗雷明汉姆冠心病预测评分的验证：多民族调查结果
JAMA. 2001 Jul 11;286(2):180-7. doi: 10.1001/jama.286.2.180.
8
Using the Framingham model to predict heart disease in the United Kingdom: retrospective study.运用弗明汉模型预测英国的心脏病：回顾性研究。
BMJ. 2000 Mar 11;320(7236):676-7. doi: 10.1136/bmj.320.7236.676.
9
Comparison of the Framingham risk function-based coronary chart with risk function from an Italian population study.基于弗明汉风险函数的冠心病图表与意大利人群研究风险函数的比较。
Eur Heart J. 2000 Mar;21(5):365-70. doi: 10.1053/euhj.1999.1864.
10
Contribution of trends in survival and coronary-event rates to changes in coronary heart disease mortality: 10-year results from 37 WHO MONICA project populations. Monitoring trends and determinants in cardiovascular disease.生存趋势和冠心病事件发生率对冠心病死亡率变化的贡献：来自世界卫生组织MONICA项目37个群体的10年结果。监测心血管疾病的趋势和决定因素。
Lancet. 1999 May 8;353(9164):1547-57. doi: 10.1016/s0140-6736(99)04021-0.
Zotero 插件